Stockreport

Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chronic Immune Thrombocytopenia (ITP)

DOVA PHARMACEUTICALS  (DOVA) 
Last dova pharmaceuticals earnings: 11/12 06:05 am Check Earnings Report
US:NASDAQ Investor Relations: investors.dova.com/investor-relations
PDF DURHAM, N.C., July 19, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a pharmaceutical company focused on acquiring, developing and commercializin [Read more]